Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8301-8310 Newer>

Pharmaceutical Executive April 1, 2012	Medical Meetings: Docs Speak Out Three physicians took the stage at the fourth annual West Coast Life Sciences Meeting Management Forum to explain their perspective on healthcare reform, online versus live education, and more.
Pharmaceutical Executive April 1, 2012	Country Report: Ukraine Despite the severe blow to its economy, Ukraine has been recovering at a faster rate than its Western European counterparts. But what has such rapid development done for the country's healthcare?
Pharmaceutical Executive April 1, 2012	Special Section: Sunshine Act Still in the Shade Phase in of the Sunshine Act will force a reconsideration of the ethical consequences of all types of pharma meetings. How and to what extent remains to be seen.
Pharmaceutical Executive April 1, 2012 William Looney	IP: Time for a Reset? Patents are the chief incentive for drug development. Industry should educate stakeholders about IP protection as a crucial driver of innovation, before it's too late.
Chemistry World April 3, 2012 Helen Gray	Mass spectrometry imaging: the new tool in counterfeit security The ever-increasing sophistication of the counterfeit trade is a growing economic problem, and when applied to pharmaceuticals, dangerous to human health.
Chemistry World April 2012 Derek Lowe	Column: In the Pipeline How long is 'too long' in the drug discovery game?
Chemistry World March 23, 2012 Rebecca Trager	Court throws out patent covering drug dosing The US Supreme Court has said that medical tests that rely on correlations between drug doses and treatment cannot be patented because they are based on laws of nature.
Chemistry World March 22, 2012 Andrew Turley	GSK to build 350 million factory in UK GlaxoSmithKline has announced plans to build its first new UK production plant for almost 40 years in Ulverston, Cumbria.
Chemistry World March 20, 2012 Rajesh Parishwad	India Green Lights Production of Patented Cancer Drug For the first time India has invoked a 'compulsory license' clause to cut the cost of a patented anti-cancer drug by allowing another company to manufacture the therapy.
Fast Company April 2012 Ted Greenwald	Ekso's Exoskeletons Let Paraplegics Walk. Now All It Has To Do Is Convince The World They're Necessary. Ekso Bionics builds robotic exoskeletons that can help paraplegics walk. All CEO Eythor Bender has to do is create a market for a product that no one knew they wanted.
<Older 8301-8310 Newer> Return to current articles.